Lupin India Revenue and Competitors

Welcome to Lupin India’s Knowledge platform, a forum specially designed to share curated medical knowledge with you. Lupin India, the fifth largest pharmaceutical company in the Indian Pharmaceutical Market (IPM) by value, contributes nearly quarter of Lupin Limited revenues. In last decade, Lupin India has grown faster than the market and emerged as a significant player in the space of Cardiology, Respiratory & Diabetology. Lupin India has been recognized as a preferred partner by the multi-nationals vying to grow their business in India. Strong field force, well-balanced product pipeline and committed leadership team makes Lupin India a promising player in the IPM. In our endeavor to partner with medical practitioners, we have developed this platform to provide valuable content including healthcare news and best practices. At Lupin we always strive to add value to your medical practice and this platform is one such initiative to address the unique needs of healthcare professionals. Less a social page, and more a learning and collaborative platform, Lupin India, intends to keep the medical fraternity abreast with clinically relevant and medically advanced information. The platform will empower the medical community to make better clinical decisions by facilitating the exchange of information, patient case studies, treatment guidelines, latest medical news and use of technology in healthcare. Let us make this platform a knowledge sharing marvel and use the networking capabilities to engage with the entire Medical Fraternity.